← Back to patent-cliff list
CAS 114341-88-7
3-(2-Bromopropanoyl)-4,4-dimethyl-1,3-oxazolidin-2-one
Codes: Imipenem-068
Application context (from source-drug indications)
Bacterial pneumoniaCilastatin Sodium/Imipenem/RelebactamHospital-acquired pneumoniaCilastatin Sodium/Imipenem/RelebactamInfectious diseaseCilastatin Sodium/Imipenem/RelebactamBacteraemiaCilastatin Sodium/Imipenem/RelebactamVentilator-associated pneumoniaCilastatin Sodium/Imipenem/RelebactamHealthcare-associated pneumoniaCilastatin Sodium/Imipenem/RelebactamBacterial infectionImipenemGonorrhoeaImipenemBacillus anthracis infectionImipenem
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Cilastatin Sodium/Imipenem/Relebactam | Tier C — Watch / trade | - |
| Imipenem | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,2-Dimethylaminoethanol→Chloridocarbonic acid trichloromethyl ester→4,4-Dimethyl-1,3-oxazolidin-2-one→2-Bromopropanoyl bromide→3-(2-Bromopropanoyl)-4,4-dimethyl-1,3-oxazolidin-2-one
2,2-Dimethylaminoethanol→Chloridocarbonic acid trichloromethyl ester→4,4-Dimethyl-1,3-oxazolidin-2-one→2-Bromopropanoyl bromide→3-(2-Bromopropanoyl)-4,4-dimethyl-1,3-oxazolidin-2-one
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.